Lauren Wilson, MPH

Associate Director, Evidence Strategy
Genesis Research Group (at the time of the study)

Poster(s):

• (131) Impact of triptan insufficient response on medication use, health care utilization, and costs: a retrospective claims study
  Wednesday, October 29, 2025

• (132) Health care resource utilization and economic burden in patients cycling through multiple triptans for migraines: a retrospective analysis
  Wednesday, October 29, 2025

• (355) Real-world switch rates of injectable migraine preventive therapies in patients with chronic migraine
  Wednesday, October 29, 2025